Oncoclinicas do Brasil (ONCO3) — Cash Flow Quality Index
Oncoclinicas do Brasil (ONCO3) has a Cash Flow Quality Index of 35.94x as of September 2024. Operating cash flow of R$112.14 Million exceeds net income of R$3.12 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Oncoclinicas do Brasil to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Oncoclinicas do Brasil Cash Flow Quality Index (2013–2023)
Historical Cash Flow Quality Index for Oncoclinicas do Brasil across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Oncoclinicas do Brasil operating cash flow efficiency.
Annual Cash Flow Quality Index for Oncoclinicas do Brasil (2013–2023)
Year-by-year earnings quality comparison for Oncoclinicas do Brasil.
| Year | Quality Index | Operating CF (BRL) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.23x | R$-51.56 Million | R$223.62 Million | ▲ +90.3% |
| 2022 | -2.39x | R$-271.64 Million | R$113.77 Million | ▼ -147.0% |
| 2019 | 5.08x | R$97.08 Million | R$19.10 Million | ▲ +112.7% |
| 2018 | 2.39x | R$38.86 Million | R$16.26 Million | ▼ -94.4% |
| 2017 | 43.01x | R$135.26 Million | R$3.15 Million | ▲ +11910.7% |
| 2013 | 0.36x | R$7.34 Million | R$20.50 Million | — |